<?xml version="1.0" encoding="UTF-8"?>
<p>Importantly, metformin treatment in the MPTP mouse model of parkinsonism improves motor function, protects dopaminergic neurons, and increases levels of the brain derived neurotrophic factor [
 <xref rid="ref093" ref-type="bibr">93â€“96</xref>]. A trial with diabetes patients revealed that Glo1 activity was increased after metformin administration [
 <xref rid="ref097" ref-type="bibr">97</xref>].
</p>
